BioXcel’s phase 3 schizophrenia film has blockbuster potential, say analysts

A sublingual film for acute agitation in schizophrenia and bipolar disorder from BioXcel has blockbuster potential that could pose a threat to an inhaled rival from Galen, according to analysts.